If you would like to submit a proposal for an oral or poster presentation at this
meeting, please click the 'submit abstract' button to view the information required
for your submission.
When ready just return to this page and fill out the form accordingly.
All abstracts will be reviewed by the Scientific Advisory Board and applicants will
be notified of the result in due course.
Successful applicants will be provided with all necessary information.
Abstract Content:
- Written in English
- Written in the third person
- Include title, name(s) and affiliation(s) of the authors
- Between 100 - 200 words
- Suitable for direct publication in the proceedings pack and on the website
- Related to the subject of the conference
Agenda Topics- 505(b)2 – Innovations for US Market
- Academic Innovations in Formulation Development
- Bioequivalence Strategies for Oral Extended / Modified Release Formulations
- Biowaiver Strategies for BCS -1 to BCS -3 Oral Solids Dosage Forms
- Delivery of Protein Therapeutics & Biologicals
- Formulation of Water Insoluble Drugs for IV Injections
- Lipid Based Drug Delivery Systems
- QbD Approaches in Formulation Development
- Solubility & Oral Bioavailability Enhancement
- Spray Systems for Nasal and Permeation Enhanced Topical Preparations
- Stability Issues with Formulations and Complex Generics
- Strategies for Herbal Medicines
- Taste Masking & Stability of Pediatric PFOS Dosage Forms
- Temperature or Moisture Sensitive / Difficult to Formulate FDC Development Approaches
Copyrights
The presenting author/person who submitted the abstract assumes full responsibility
of the content of the abstract and we assume that all co-authors are aware of this
content. Please note that your biography, summary and abstract may be used on this
website and conference materials.
|
